Dr. Rudensky is a Howard Hughes Medical Institute Investigator, a Tri-Institutional Professor at Memorial Sloan-Kettering Cancer Center, the Rockefeller University, and Cornell University, and Professor Tri-Institutional Professor at MSKCC, the Rockefeller University and Cornell University, and Professor at Gerstner School of Graduate Studies and at Weill-Cornell Medical School.
He is an internationally-recognized leader in the field of immune regulation, where he has made numerous seminal discoveries including the identification of the molecular mechanisms of regulatory T cell differentiation.
Dr. Rudensky is a member of the Scientific Advisory Board of Tempero Pharmaceuticals and was elected to the National Academy of Sciences in 2012.